Publicacións (176) Publicacións nas que participase algún/ha investigador/a

filter_list

2025

  1. A physiologically based pharmacokinetic model to describe [89Zr]Zr-DFO-Adalimumab specific activity after intravitreal administration to rats with endotoxin-induced uveitis

    International Journal of Pharmaceutics, Vol. 681

  2. Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis

    Nature communications, Vol. 16, Núm. 1, pp. 229

  3. Blood Progenitor Cell Mobilization Driven by TWEAK Promotes Neovascularization and Reduces Brain Damage in a Rat Model of Intracerebral Hemorrhage

    Antioxidants, Vol. 14, Núm. 5

  4. Design and characterization of intravitreal bevacizumab-loaded PLGA nanoparticles: pharmacokinetic and biodistribution impact

    Drug Delivery and Translational Research

  5. Evaluation of the two-voltage method for parallel-plate ionization chambers irradiated with pulsed beams

    Medical Physics, Vol. 52, Núm. 6, pp. 4894-4909

  6. Frequency and Clinical Outcomes Associated with Tau Positron Emission Tomography Positivity

    JAMA

  7. Hypometabolism and atrophy patterns associated with Niemann-Pick type C

    EJNMMI Research, Vol. 15, Núm. 1

  8. Intracerebroventricular phospho-tau immunotherapy alleviates cortical phospho-tau burden and motor phenotype in a neuron-specific P301S tauopathy mouse

    Experimental Neurology, Vol. 391

  9. Intravitreal Administration of Adalimumab-Loaded Poly(Lactic-co-Glycolic Acid) Nanoparticles: Effects on Biodistribution and Pharmacokinetics

    Small Science

  10. Lecanemab approval in EU: what should we be ready for?– the EANM perspective

    European Journal of Nuclear Medicine and Molecular Imaging

  11. Mini-GRID therapy delivers optimised spatially fractionated radiation therapy using a flattening free filter accelerator

    Communications Medicine, Vol. 5, Núm. 1

  12. Model to predict the risk of cardiac death based on clinical characteristics and Gated-SPECT parameters

    Revista Espanola de Medicina Nuclear e Imagen Molecular

  13. Neuroprotective effect of small extracellular vesicle-mediated targeting of AMPKα2 in cerebral ischemia

    Metabolism: Clinical and Experimental, Vol. 167

  14. PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model

    International Journal of Pharmaceutics, Vol. 669

2024

  1. 18F-FDG positron emission tomography as a marker of disease activity and treatment response in ankylosing spondylitis and psoriatic arthritis

    Scientific Reports, Vol. 14, Núm. 1

  2. An in-silico study of conventional and FLASH radiotherapy iso-effectiveness: potential impact of radiolytic oxygen depletion on tumor growth curves and tumor control probability

    Physics in medicine and biology, Vol. 69, Núm. 21

  3. Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models

    International Journal of Pharmaceutics, Vol. 652

  4. Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study

    International Journal of Molecular Sciences, Vol. 25, Núm. 18

  5. Correction to: EANM perspectives for CZT SPECT in brain applications (European Journal of Nuclear Medicine and Molecular Imaging, (2024), 51, 12, (3680-3684), 10.1007/s00259-024-06788-6)

    European Journal of Nuclear Medicine and Molecular Imaging

  6. EANM perspectives for CZT SPECT in brain applications

    European Journal of Nuclear Medicine and Molecular Imaging